The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.
about
Finding new components of the target of rapamycin (TOR) signaling network through chemical genetics and proteome chipsSignaling by target of rapamycin proteins in cell growth controlGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae.mTOR inhibitors in advanced renal cell carcinomaThe mTOR signalling pathway in human cancerRoles of mTOR Signaling in Brain DevelopmentPI3K-AKT-mTOR-signaling and beyond: the complex network in gastroenteropancreatic neuroendocrine neoplasmsThe role of placental nutrient sensing in maternal-fetal resource allocationThe balance of protein expression and degradation: an ESCRTs point of viewNutrient-sensing mechanisms across evolutionIndependent and Cooperative Antiviral Actions of Beta Interferon and Gamma Interferon against Herpes Simplex Virus Replication in Primary Human FibroblastsA genome-wide screen for regulators of TORC1 in response to amino acid starvation reveals a conserved Npr2/3 complexHsf1 activation inhibits rapamycin resistance and TOR signaling in yeast revealed by combined proteomic and genetic analysisAdipose tissue dysfunction and its effects on tumor metabolismMondoA-Mlx transcriptional activity is limited by mTOR-MondoA interactionLactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoARNA-seq characterization of spinal cord injury transcriptome in acute/subacute phases: a resource for understanding the pathology at the systems levelMetabolic control by S6 kinases depends on dietary lipidsRegulation of the mTOR complex 1 pathway by nutrients, growth factors, and stressActivation of a metabolic gene regulatory network downstream of mTOR complex 1TOR signaling.Cell growth control: little eukaryotes make big contributions.Soy Isoflavones Regulate Lipid Metabolism through an AKT/mTORC1 Pathway in Diet-Induced Obesity (DIO) Male Rats.Transcriptional Characterization of Compounds: Lessons Learned from the Public LINCS Data.A library of gene expression signatures to illuminate normal and pathological lymphoid biology.An approach to analyse the specific impact of rapamycin on mRNA-ribosome association.Transcription factor regulation can be accurately predicted from the presence of target gene signatures in microarray gene expression data.Direct control of mitochondrial function by mTOR.Enhancing CD8 T-cell memory by modulating fatty acid metabolismMuscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.Effects of Rapamycin on Clinical Manifestations and Blood Lipid Parameters in Different Preeclampsia-like Mouse ModelsQuantitative nuclear proteomics identifies mTOR regulation of DNA damage response.Activation of the AMP-activated protein kinase-p38 MAP kinase pathway mediates apoptosis induced by conjugated linoleic acid in p53-mutant mouse mammary tumor cells.mTORC1 activates SREBP-1c and uncouples lipogenesis from gluconeogenesis.Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesisFrom mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis.Amino acid availability controls TRB3 transcription in liver through the GCN2/eIF2α/ATF4 pathwayISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy.mTOR signaling in lymphangioleiomyomatosis
P2860
Q24314346-544D43CB-A61F-4D9C-9619-4DB7BA82D16DQ24522447-439DC988-0DEC-4B5D-B801-D9D985417437Q24536351-D73D972B-0210-4E42-8E40-51CBF114A53EQ24537557-24BAD558-A84B-46B7-A885-BEBD9A764AF8Q24612127-ABF8DB63-D294-458A-9973-2CF35CB1D291Q24627306-FE17E9C3-8F42-4654-BFFB-6BE18F6666EBQ26786097-9EC59C33-4216-4D2E-89B4-B6BE5EB1B989Q26862544-D378A79E-EA4A-4D96-A1B6-2F2A5711A8C5Q27008068-8D794E5E-3948-45C3-9130-7974AFCDD92EQ27014321-BA246D39-8976-4A5C-8400-C7863D41F45EQ27015819-D119B88D-2774-46D3-97E3-E8417FA7B755Q27485444-7341DF17-D687-4CAF-8219-5CD968B6A2F9Q27938995-5C7A4D52-D51B-4DE5-AC34-CB625E05C66CQ27939652-2684A1C3-9EA6-4CDA-BA48-D294CA7E025DQ28080748-60EDB1B0-1CE1-43F4-9AD6-11D61377AD05Q28385939-2253EACA-A666-466C-AD1A-77296F2C3397Q28475481-2225F339-5B29-4307-89ED-D6A91A1866F8Q28535228-88576835-F59F-4B16-B60D-0E37479661A5Q28731457-C1C38D81-D9D2-4BF6-880B-DC54A38D797CQ29614493-A1D6591C-983E-48B8-8F03-12AC05951CB7Q29615179-54A0158D-AF66-4BE1-8FE2-A942EA6775BEQ30312086-085626CF-53A5-47BA-BC46-C192CF131A35Q30357437-7E747BFC-EEB1-4333-AA38-E97104BB0EADQ30387784-75726754-4453-41FA-8822-623038D09100Q31096726-E20F2932-F185-4F99-AA14-3CEAAEFADBF4Q33240316-9D7BB258-192C-4D73-AE3C-51EC9FE847CFQ33357019-758DB97A-A38D-4BE9-BDBC-E17FC95BC2E6Q33538943-573DF40C-566A-4AAA-BE24-F1F013F7046AQ33552261-24E17ACA-F5CE-4504-BDE0-CBFC348AED55Q33577204-D3D62DAA-9A29-4FFC-AD3D-4B58E93C2B82Q33589972-032913D0-1E71-42DE-A5A9-BC969918D86CQ33646644-B1BB4D6A-F11E-4A4C-9566-28F1E6008D3AQ33697806-91F57502-6E94-43FC-863A-F957B582B95EQ33727103-B8D06E1A-5030-4063-BE27-650E92A8B62CQ33734395-A4B174F6-79FD-4E70-BEDE-B92D2BEC825DQ33734679-2DEDE177-624B-49A2-947B-ED0A74A917D0Q33750454-954A395E-493C-451F-A812-1889B722152EQ33784832-075B0F31-48B4-46E6-8C0C-61A3D0F73750Q33864174-64D4A18E-07BD-4903-BF63-6C5879DA3B39Q33905253-1BD09C38-4F0A-4AF2-ADC3-1BBBB9EAE2E9
P2860
The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation.
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@ast
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@en
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@nl
type
label
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@ast
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@en
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@nl
prefLabel
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@ast
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@en
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@nl
P2093
P2860
P1476
The immunosuppressant rapamyci ...... acid and glucose deprivation.
@en
P2093
David M Sabatini
Todd R Golub
P2860
P304
P356
10.1128/MCB.22.15.5575-5584.2002
P407
P577
2002-08-01T00:00:00Z